CHOOLIP & SCIENCES Inc.
Research CHOOLIP & SCIENCES Inc. (291650.KQ) on Bullrun: market cap KRW 79.20B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker291650.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 79.20B
- Financial periodQ2 2026
- RevenueKRW 2.39B
- Net income-KRW 4.26B
- Gross margin41.8%
Valuation Snapshot
latest market cap is KRW 79.20B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | -KRW 9.69B | n/a | n/a | KRW 21.38B | KRW 7.56B | KRW 28.23B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 79.20B | n/a | n/a | n/a |
Dividend history
About CHOOLIP & SCIENCES Inc.
CHOOLIP & SCIENCES Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company's platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders. It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CHOOLIP & SCIENCES Inc.'s market cap?
CHOOLIP & SCIENCES Inc.'s market capitalization is KRW 79.20B.
What does CHOOLIP & SCIENCES Inc. do?
CHOOLIP & SCIENCES Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company's platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders. It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer. The company was formerly known as Aptamer Sciences Inc and changed its name to CHOOLIP & SCIENCES Inc. in August 2026.